期刊文献+

^(99m)Tc-HL91肺癌乏氧显像临床价值研究 被引量:2

^(99m)Tc- HL91 Hypoxic Scintigraphy for Lung Cancer
下载PDF
导出
摘要 【目的】探讨乏氧组织显像剂99mTc-HL91显像对肺癌诊断价值及与放射治疗前后肿瘤乏氧程度的改变。【方法】选取确诊的肺癌病例41例,非肺癌病例33例为实验组和对照组。实验组于放射治疗前后1,6h行99mTc-HL91肺癌乏氧显像并测定其T/NT比值,放疗后前后4h行CT+SPECT断层显像并测定T/NT比值;对照组行肺部1,6h99mTc-HL91肺癌乏氧显像。【结果】41例肺癌患者治疗前均可见病灶处放射性分布早期增加,血流灌注峰与邻近正常组织比较明显增加。治疗前1、6h平面显像T/NT值分别为1.2024±0.0745,1.4659±0.0820;治疗后1、6分别为1.0895±0.0553,1.2163±0.0694。治疗前后比较,P=0.000。对照组33例,1、6h平面显像双肺对应感兴趣区T/NT分别为0.978±0.055和0.980±0.030。肺癌组与对照组1h,6hT/NT值比较,差异有显著性,P=0.000。放疗后1、6h分别为1.0895±0.0553,1.2163±0.0694。治疗前后比较,P=0.000。放疗后1h,低度乏氧(1.0888<T/NT≤1.2024)18例,其疗效CR9例,PR8例,SD1例,PD0例;高度乏氧(T/NT>1.2024)23例,其疗效CR0例,PR18例,SD3例,PD2例。放疗后6h低度乏氧(1.0898<T/NT≤1.4659)22例,其疗效CR9例,PR12例,SD1例,PD0例;高度乏氧(T/NT>1.4659)19例,其疗效CR0例,PR14例,SD3例,PD2例。放疗疗效和乏氧程度分布有显著统计学差异(P<0.05)。【结论】99mTc-HL91能检测肺癌乏氧与否及其程度,可作为评价肺癌乏氧程度的一种辅助手段;肺癌患者放疗前后99mTc-HL91乏氧显像T/NT值分布有明显差异,其乏氧程度和放疗疗效关系密切,可作为肺癌放疗疗效预测的手段之一。 [Ohjective] To evaluate the etIicacy of ^99mTc-HL91 hypoxic imaging for lung cancer. [Methods] From January 2002 to October 2005, 41 patients with lung cancer were enrolled in the cfinical research and accepted hypoxic seintigraphy of ^99mTc- HL91 post- and after radiotherapy. The other 33 patients with non-lung cancer accepted hypoxic seintigraphy of ^99mTc- HL91 also. T/NT ratio also were ohtainod in 1, 4, and 6 hours after injecting ^99mTc- HLgl solution. [Results] In lung cancer group, radioactivity accumulation were present in all lung cancer patients. 1 hour and 6 hours before radiotherapy, the T/NT ratio were 1.2024±0.0745 and 1.4659±0.0820; 1 and 6 hour after radiotherapy, the T/NT ratio were 1.0895±0.0553 and 1.2163±0.0694. In non-lung cancer group, the T/NT ratio were 0.978±0.055 and 0.980±0.030. The two groups had statistical difference in 1 and 6 hour after injecting ^99mTc- HL91 solution. 1 and 6 hour after radiotherapy, the T/NT ratio were 1.0895±0.0553 and 1.2163±0.0694. In non-lung cancer group, the T/NT ratio were 0.978±0.055 and 0.980±0.030. There were statistical difference in 1 and 6 hours before and after injecting ^99mTc- HL91 solution. One hour after radiotherapy,18 cases showed low-hypoxic including CR 9 cases, PR 8 cases, SD 1 case, and PD 0 case; 23 cases showed high-hypoxic including CR 0 cases, PR 18 cases, SD 3 case, and PD 2 case. 6 hours after radiotherapy, 22 cases showed low-hypoxic including CR 9 cases, PR 12 cases, SD 1 case, and PD 0 case; 19 cases showed high -hypoxic including CR 0 cases, PR 14 cases, SD 3 case, and PD 2 case. [Conclusions] Lung cancer shows high sensibility to hypoxic cell.^99mTc- HL91 hypoxic scintigraphy for lung cancer is available and usefti. There was close relation between the degree of ^99mTc- HL91 hypoxic scintigraphy and the effects of radiotherapy for the patients with lung cancer.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2007年第2期205-208,213,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科委科技计划项目(2001年C30308)
关键词 肺癌 乏氧显像 放射治疗 lung cancer hypoxic scintigraphy technetium radiotherapy
  • 相关文献

参考文献13

  • 1BUSH R S,JENKIN R D,ALLT W E,et al,Definitive evidence for hypoxic cell influencing cure in cancer therapy[J].Br J Cancer,1978,37,Suppl:302-306.
  • 2RAEBER T G,OSMANIAN C,JACKS T,et al.Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours[J].Nature,1996,379(6560):88-91.
  • 3HOCHEL M,SCHLENGER K,MITZE M,et al.Hypoxia and radiated response in human tumors[J].Semin in Radiat Oncol,1996,29(6):3-9.
  • 4朱霖.乏氧组织显像剂及其应用[J].国外医学(放射医学核医学分册),1997,21(4):150-154. 被引量:10
  • 5李莉.乏氧组织显像剂研究最新进展[J].国外医学(放射医学核医学分册),1999,23(3):134-139. 被引量:14
  • 6TATSUMI M,YUTANI K,KUSUOKA H,et al.Technetium-99m HL91 uptake as a tumour hypoxia marker:relationship to tumour blood flow[J].Eur J Nucl Med,1999,26(2):91-94.
  • 7COOK G J,HOUSTON S,BARRINGTON S F,et al.99mTc-HL91 labeled HL91 to identify tumor hypoxia:correlation with 18FDG[J].J Nucl Med,1998,39(1):99-103.
  • 8HIGASHI K,UEDA Y,MATSUNARI I,et al.11Cacetate PET imaging of lung cancer:comparison with 18F-FDG PET and 99mTc-MIBI SPET[J].Eur J Nucl Med Mol Imaging,2004,31(1):13-21.
  • 9PLACHCINSKA A,MIKOLAJCZAK R,MAECKE H,et al.Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics:a pilot study[J].Cancer Biother Radiopharm,2004,19(2):261-270.
  • 10MARTINS T,LINO J S,RAMOS S,et al.99mTcdepreotide scintigraphy in the evaluation of indeterminate pulmonary lesions:clinical experience[J].Cancer Biother Radiopharm,2004,19(2):253-259.

共引文献20

同被引文献20

  • 1李永军,包丽华,徐兆强,李殿富,王德杭,卢凯华.肺部良性疾病摄取^(99)Tc^m-HL91特点临床研究[J].实用放射学杂志,2006,22(5):600-602. 被引量:3
  • 2李永军,包丽华,徐兆强,李殿富,王德杭,卢凯华,李田.^(99)Tc^m-HL91乏氧显像预测局部晚期非小细胞肺癌放疗敏感性[J].实用放射学杂志,2006,22(11):1391-1394. 被引量:2
  • 3Barnea G, Silvennoinen O, Shaanan B, et al. Identification of a calbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases. Mol Cell Biol, 1993, 13(3): 1497-1506.
  • 4Pastorekova S, Pastorek J. Cancer-related carbonicanhydrase isozymes and their inhibition [A]. Supuran CT. Carbonic anhydrase. Its Inhibitors and activators [M]. RocaRaton, FL: CRC Press, 2004. 255-281.
  • 5Swinson DE, Cox G, O'Byrne KJ, et al. Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer. Br J Cancer, 2004, 91 (7): 1301-1307.
  • 6Simi L, Venturini G, Malentacchi F, et al. Quantitative analysis of carbonic anhydrase IX mRNA in human non-sman cell lung cancer. Lung Cancer, 2006, 52(1): 59-66.
  • 7Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Expression of hypoxia- inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res, 2001, 61(21): 7992-7998.
  • 8Le QT, Chen E, Salim A, et al. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res, 2006, 12(5): 1507-1514.
  • 9Kim SJ, Rabbani ZN, Dewhirst MW, et al. Expression of HIF-1 alpha, CAIX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer, 2005, 49(3): 325-335.
  • 10Raghunand N, Mahoney BP, Gillies RJ, et al. Tumor acidityj ion trapping and chemotherapeutics. Ⅱ. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol, 2003, 66(7): 1219-1229.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部